The Safety and Efficacy of Prolonged Use of Bedaquiline for the Treatment of Patients with Pulmonary Multi-Drug Resistant/Rifampin-Resistant Tuberculosis: A Prospective, Cohort Study in China-Reference-Cited by-全球学者库

登录注册会员服务联系我们

The Safety and Efficacy of Prolonged Use of Bedaquiline for the Treatment of Patients with Pulmonary Multi-Drug Resistant/Rifampin-Resistant Tuberculosis: A Prospective, Cohort Study in China

Published:2023-08 Issue: Volume:Volume 16 Page:5055-5064
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Ke Hui,Gui Xuwei,Sun Wenwen,Zhang Shaojun,Yang Yan,Zhang Zhemin,Fan Lin^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference40 articles.

1. World Health Organization. Global tuberculosis report 2014. Geneva: World Health Organization. 2014. Available from: www.who.int/about/licensing/copyright_form/en/index.html. Accessed July 27, 2023.

2. World Health Organization. Global tuberculosis report 2017. Licence: CC BY-NCSA 30 IGO. Geneva: World Health Organization; 2017.

3. World Health Organization. Global tuberculosis report 2022. License: CC BY-NC-SA 3.0 IGO. Geneva: World Health Organization; 2022.

4. Assessment of multidrug-resistant tuberculosis (MDR-TB) treatment outcomes in Sudan; findings and implications

5. Achieving high treatment success for multidrug-resistant TB in Africa: initiation and scale-up of MDR TB care in Ethiopia—an observational cohort study

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前全球学者库共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP